Arrowhead Pharmaceuticals, Inc.

LAZARD ASSET MANAGEMENT LLC ARWR

Report date

3/31/2026

Quarter

2026 Q1

Filed

5/15/2026

Shares

4,567

Value ($000)

286

Weight

0.0%

2019 Q4 - 2026 Q1 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q1	5/15/2026	286	0.0%	4,567	3/31/2026
2025 Q2	8/14/2025	91	0.0%	5,771	6/30/2025
2024 Q4	2/14/2025	0	0.0%	19	12/31/2024
2024 Q3	11/14/2024	0	0.0%	19	9/30/2024
2024 Q2	8/14/2024	59	0.0%	2,328	6/30/2024
2024 Q1	7/9/2024	102	0.0%	3,629	3/31/2024
2023 Q4	2/14/2024	123	0.0%	4,065	12/31/2023
2023 Q3	11/14/2023	107	0.0%	4,018	9/30/2023
2023 Q2	8/15/2023	85	0.0%	2,429	6/30/2023
2023 Q1	5/15/2023	94	0.0%	3,713	3/31/2023
2022 Q4	2/15/2023	127	0.0%	3,147	12/31/2022
2022 Q3	11/14/2022	125	0.0%	3,811	9/30/2022
2022 Q2	8/9/2022	133	0.0%	3,804	6/30/2022
2022 Q1	5/13/2022	87	0.0%	1,927	3/31/2022
2021 Q4	2/9/2022	92	0.0%	1,403	12/31/2021
2021 Q3	11/15/2021	1,675	0.0%	26,847	9/30/2021
2021 Q2	8/12/2021	209	0.0%	2,530	6/30/2021
2021 Q1	5/14/2021	2	0.0%	37	3/31/2021
2020 Q4	2/11/2021	2	0.0%	37	12/31/2020
2019 Q4	2/13/2020	47	0.0%	750	12/31/2019